IDEXX Laboratories Shares Bought by Azimuth Capital Investment Management

Institutional investor increased stake in veterinary diagnostics company by over 34% in Q3

Mar. 15, 2026 at 8:35am

Got story updates? Submit your updates here. ›

Azimuth Capital Investment Management LLC, an institutional investor, grew its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 34.6% during the third quarter of 2026, according to a recent SEC filing. The firm now owns 31,962 shares of the company's stock, valued at $20.42 million.

Why it matters

IDEXX Laboratories is a leading global provider of diagnostic instruments, consumables and software for the veterinary industry. The company's strong performance and growth have attracted significant institutional investor interest, as evidenced by Azimuth Capital's increased stake.

The details

Azimuth Capital Investment Management LLC acquired an additional 8,212 shares of IDEXX Laboratories during the third quarter, bringing its total position to 31,962 shares. IDEXX Laboratories is a major holding for the investment firm, which focuses on healthcare and technology stocks.

  • Azimuth Capital increased its IDEXX Laboratories stake during Q3 2026.

The players

Azimuth Capital Investment Management LLC

An institutional investment firm that focuses on healthcare and technology stocks.

IDEXX Laboratories, Inc.

A global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

IDEXX Laboratories' strong performance and growth continue to attract significant institutional investor interest, as evidenced by Azimuth Capital Investment Management's increased stake in the company. This highlights the veterinary diagnostics firm's position as a leader in its industry.